ADAP
Adaptimmune Therapeutics
ADAP
ADAP
93 hedge funds and large institutions have $888M invested in Adaptimmune Therapeutics in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 36 reducing their positions, and 11 closing their positions.
Holders
93
Holders Change
+7
Holders Change %
+8.14%
% of All Funds
2.13%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
18
Increased
18
Reduced
36
Closed
11
Calls
$10.3M
Puts
$2.56M
Net Calls
+$7.74M
Net Calls Change
+$6.31M